These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4958832)

  • 21. Effectiveness of antibiotics against the bacterial and "protoplast" phases of pyelonephritis.
    Montgomerie JZ; Kalmanson GM; Hewitt WL; Guze LB
    Antimicrob Agents Chemother (Bethesda); 1965; 5():427-30. PubMed ID: 4956799
    [No Abstract]   [Full Text] [Related]  

  • 22. A transmembrane pH gradient in Streptococcus faecalis: origin, and dissipation by proton conductors and N,N'-dicyclohexylcarbodimide.
    Harold FM; Pavlasová E; Baarda JR
    Biochim Biophys Acta; 1970; 196(2):235-44. PubMed ID: 4244306
    [No Abstract]   [Full Text] [Related]  

  • 23. Improved m-Enterococcus agar for counting faecal streptococci in sea water.
    Mates A; Bar-Dov L; Ghinsburg R
    Microbios; 1994; 79(319):97-100. PubMed ID: 7968665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.
    Kanafani ZA; Federspiel JJ; Fowler VG
    Scand J Infect Dis; 2007; 39(1):75-7. PubMed ID: 17366018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial effect of two mineral trioxide aggregate (MTA) preparations against Enterococcus faecalis and Streptococcus sanguis in vitro.
    Al-Hezaimi K; Al-Shalan TA; Naghshbandi J; Oglesby S; Simon JH; Rotstein I
    J Endod; 2006 Nov; 32(11):1053-6. PubMed ID: 17055905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daptomycin resistance in Enterococcus faecalis prosthetic valve endocarditis.
    Hidron AI; Schuetz AN; Nolte FS; Gould CV; Osborn MK
    J Antimicrob Chemother; 2008 Jun; 61(6):1394-6. PubMed ID: 18344547
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of the role of antibiotics and enterococcal virulence factors in a mouse model of extraintestinal translocation.
    Krueger WA; Krueger-Rameck S; Koch S; Carey V; Pier GB; Huebner J
    Crit Care Med; 2004 Feb; 32(2):467-71. PubMed ID: 14758165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada.
    Boyd DA; Du T; Hizon R; Kaplen B; Murphy T; Tyler S; Brown S; Jamieson F; Weiss K; Mulvey MR
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2217-21. PubMed ID: 16723588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
    Socha AM; Laplante KL; Russell DJ; Rowley DC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium.
    Yoong P; Schuch R; Nelson D; Fischetti VA
    J Bacteriol; 2004 Jul; 186(14):4808-12. PubMed ID: 15231813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient.
    Werner G; Gfrörer S; Fleige C; Witte W; Klare I
    J Antimicrob Chemother; 2008 May; 61(5):1182-3. PubMed ID: 18285315
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Licci A; Lukasiak J; Scalise G
    J Antimicrob Chemother; 2005 Feb; 55(2):272-4. PubMed ID: 15649993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of some compounds on the adenosine triphosphatase activity of Streptococcus faecalis.
    Santos Mota JM; Carvalho Guerra F
    Experientia; 1969 Mar; 25(3):249-50. PubMed ID: 4182329
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
    Munoz-Price LS; Lolans K; Quinn JP
    Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
    [No Abstract]   [Full Text] [Related]  

  • 39. Staphylococcal spheroplasts and L-colonies. 3. Induction by lysostaphin.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    J Infect Dis; 1969 Jan; 119(1):67-74. PubMed ID: 5765044
    [No Abstract]   [Full Text] [Related]  

  • 40. High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
    Garnier F; Ducancelle A; Boisset S; Pineiro A; Bergeret M; Denis F; Raymond J
    Int J Antimicrob Agents; 2004 May; 23(5):529-30. PubMed ID: 15120739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.